Ptc Therapeutics (PTCT) EBT Margin (2012 - 2026)
Ptc Therapeutics' (PTCT) quarterly EBT Margin came in at 0.9% in Q1 2026, down 7996.0% year-on-year from 0.01% in Q1 2025, and up 98.93% quarter-over-quarter from 84.46% in Q4 2025.
Ptc Therapeutics (PTCT) EBT Margin (2012 - 2026) Analysis & Trends
Ptc Therapeutics' EBT Margin history runs 15 years deep, the most recent figure standing at 0.9% for Q1 2026.
- On a quarterly basis, EBT Margin fell 7996.0% year-over-year to 0.9% in Q1 2026; TTM through Mar 2026 was 28.49%, a 10732.0% decrease from a year earlier, with the FY2025 full-year figure at 40.25%, up 1104.0% from the prior year.
- EBT Margin rose to 0.9% in Q1 2026 per PTCT's latest filing, from 84.46% in the prior quarter.
- Across five years, EBT Margin topped out at 236.48% in Q4 2024 and bottomed at 115.48% in Q4 2022.
- The 5-year median for EBT Margin is 59.92% (2023), against an average of 37.09%.
- Across the five-year window, EBT Margin jumped 31649 bps in 2024 and tumbled 32094 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 115.48% in 2022, then soared by 31 bps to 80.01% in 2023, then soared by 396 bps to 236.48% in 2024, then tumbled by 136 bps to 84.46% in 2025, then soared by 99 bps to 0.9% in 2026.
- Per Business Quant, the three latest PTCT EBT Margin figures stand at 0.9% (Q1 2026), 84.46% (Q4 2025), and 10.94% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ptc Therapeutics | 6.47 Bn | 4.58 Bn | 244.52 Mn | -0.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.90% |
| Dec 31, 2025 | -84.46% |
| Sep 30, 2025 | -10.94% |
| Jun 30, 2025 | -39.72% |
| Mar 31, 2025 | 79.06% |
| Dec 31, 2024 | 236.48% |
| Sep 30, 2024 | -49.80% |
| Mar 31, 2024 | -40.31% |
| Dec 31, 2023 | -80.01% |
| Sep 30, 2023 | -84.75% |
| Jun 30, 2023 | -111.07% |
| Mar 31, 2023 | -61.25% |
| Dec 31, 2022 | -115.48% |
| Sep 30, 2022 | -58.59% |
| Jun 30, 2022 | -89.83% |
| Mar 31, 2022 | -81.95% |
| Dec 31, 2021 | -83.89% |
| Sep 30, 2021 | -96.34% |
| Jun 30, 2021 | -101.03% |
| Mar 31, 2021 | -108.69% |